HONG KONG – China's leading vaccine maker, Sinovac Biotech Ltd., has postponed its 2016 annual report while it investigates allegations made by U.S. investment management company Geoinvesting LLC that its CEO may have been involved in bribing a CFDA official to speed up drug approvals.